AMBER LALLO: Open Payments
NPI 1013559871 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 52 payments from 10 companies in 2025. Trend: 2023 $646 · 2024 $429 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $251 |
| Paratek Pharmaceuticals, Inc. | 5 | $209 |
| Gilead Sciences, Inc. | 10 | $204 |
| ViiV Healthcare Company | 16 | $202 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Aimmune Therapeutics, Inc. | 3 | $92 |
| La Jolla Pharmaceutical Company | 3 | $66 |
| Melinta Therapeutics, LLC | 3 | $63 |
| PFIZER INC. | 1 | $25 |
| Urgo Medical North America, LLC | 1 | $24 |
Products named: NUZYRA, DOVATO, BOTOX, PIFELTRO, VOWST, Yeztugo, DALVANCE, Rezzayo.
Industry payments across PA — which companies pay providers there.
